Salicylate Toxicity & the Anion Gap

The classic mixed disorder

Salicylate toxicity is one of the canonical toxin causes of a high anion gap metabolic acidosis. Its signature is a mixed respiratory alkalosis plus high anion gap metabolic acidosis — the only common poisoning that produces this exact combination. Salicylates directly stimulate the medullary respiratory center, driving hyperventilation and a respiratory alkalosis within hours of ingestion. Later, as salicylate accumulates in tissues, it uncouples oxidative phosphorylation and disrupts Krebs-cycle enzymes, generating lactate and ketoacids that produce a parallel high-AG metabolic acidosis. Confirm the gap with the anion gap calculator and read the broader differential in our toxin-induced HAGMA guide.

Salicylate toxicity causes a mixed respiratory alkalosis (from direct stimulation of the medullary respiratory center) and high anion gap metabolic acidosis (from uncoupling of oxidative phosphorylation, producing lactate and ketoacids). The anion gap is moderately elevated; treatment is urine alkalinization with sodium bicarbonate and hemodialysis for severe acidosis, organ injury, or serum salicylate > 90–100 mg/dL.

Pathophysiology

Salicylates exert two independent effects that explain the mixed disorder. First, direct medullary stimulation increases minute ventilation, lowering PaCO₂ and producing a respiratory alkalosis — this appears first and is universal in symptomatic adults. Second, mitochondrial toxicity: salicylate uncouples oxidative phosphorylation (dissipating the proton gradient), inhibits succinate dehydrogenase and other Krebs-cycle enzymes, and stimulates lipolysis, generating lactate and ketoacids. The result is a high anion gap metabolic acidosis that worsens as absorption continues.

Two further mechanisms deepen the acidosis. Salicylates at high concentration cross the blood-brain barrier, where the lower ambient pH converts more of the drug to its non-ionized (lipid-soluble) form, accelerating CNS entry and driving the neurologic symptoms (tinnitus, confusion, seizures, coma). Renal salicylate excretion is also flow- and pH-dependent: alkaline urine ionizes salicylate and traps it in the tubular lumen, hastening clearance — the rationale for urine alkalinization.

Levels and severity

Therapeutic anti-inflammatory salicylate levels are 15–30 mg/dL; toxicity begins above 30 mg/dL, moderate toxicity is 40–60 mg/dL, and severe poisoning typically presents above 60–70 mg/dL. Levels above 90–100 mg/dL warrant hemodialysis, especially with clinical deterioration, altered mental status, pulmonary edema, refractory acidosis, or renal failure (EXTRIP Workgroup recommendations; AAPCC). Because absorption can be delayed (sustained-release preparations, bezoars, concretions), always recheck levels every 2 hours until they are clearly falling.

Treatment

1. Stabilize. Airway, breathing, circulation. Mild hyperventilation is protective — intubated patients must be hyperventilated to match their pre-intubation minute ventilation, or PaCO₂ will rise and worsen CNS salicylate entry.
2. Decontaminate. Activated charcoal (1 g/kg) within 1–2 hours of ingestion; consider repeat doses or whole-bowel irrigation for sustained-release preparations.
3. Alkalinize the urine. Sodium bicarbonate infusion (1–2 mEq/kg, then titrate) to a target urine pH 7.5–8.0 and serum pH 7.45–7.55. Alkaline urine ionizes salicylate (pKa 3.0), trapping it in the tubule and increasing clearance 5- to 10-fold. Supplement potassium aggressively — hypokalemia prevents bicarbonaturia.
4. Hemodialysis for serum salicylate > 90–100 mg/dL (or > 80 mg/dL with end-organ injury), refractory acidosis (pH < 7.20 despite bicarbonate), altered mental status or seizures, pulmonary edema, or renal failure.
5. Supportive care — fluids, glucose (cerebral hypoglycemia can occur with normal serum glucose), and electrolyte correction.

Compare with toxic alcohol poisoning — the other time-critical toxin cause of high-AG metabolic acidosis. The two are distinguished by the osmolar gap (high in toxic alcohols, normal in salicylate toxicity) and the salicylate level.

Key takeaways

• Salicylate toxicity produces a mixed respiratory alkalosis + high anion gap metabolic acidosis — a near-pathognomonic pattern.
• The anion gap reflects uncoupled oxidative phosphorylation (lactate, ketoacids); the respiratory alkalosis reflects direct medullary stimulation.
• Send a serum salicylate level and repeat every 2 hours until clearly falling.
• Treat with urine alkalinization (sodium bicarbonate + potassium) and hemodialysis for severe poisoning (> 90–100 mg/dL, organ injury, or refractory acidosis).